Syner-G Biopharma Group Announces Neil Butera as New Chief Commercial Officer
BOSTON, April 6, 2023 /PRNewswire-PRWeb/ -- Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, today announced the addition of Neil Butera as chief commercial officer. This hire deepens the bench of the C-suite team in response to the company's continued growth.
- BOSTON, April 6, 2023 /PRNewswire-PRWeb/ -- Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, today announced the addition of Neil Butera as chief commercial officer.
- "We are thrilled to have Neil join the Syner-G team," said Ron Kraus, chief executive officer, Syner-G. "His proven commercial experience in the bio-tech industry is an invaluable asset to the current leadership team.
- "I am honored to be chosen as the new chief commercial officer for Syner-G," said Neil Butera.
- "It is exciting to be a part of this innovative company whose services underpin the successful development of lifesaving therapies across the biopharma industry."